← Markets

Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF

GSSC · AMEX

Market closed$90.13$-0.600000 (-0.66%)After hours $90.13 · 0.00%

Key statistics

Previous close$90.73
Open$89.45
Day high$90.69
Day low$89.38
52-week high$92.01
52-week low$66.81
Market cap878.77M
Volume35.33K
Average volume32.58K
P/E ratio18.84
Forward P/E—
EPS4.78
Dividend yield0.00%

Market context

Why it moved

GSSC edged lower amid a broader small-cap consolidation, as the ETF pulled back slightly from near its 52-week high following a period of strong year-to-date gains, with modest selling pressure and light volume suggesting routine profit-taking rather than any specific negative catalyst.

ZacksYahoo FinanceLinkedinGovZacks

What is happening

Recent company-specific developments and publisher coverage.

July 17, 2026The Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF edged lower on Friday as a broad market selloff weighed on risk assets, with the S&P 500 falling roughly 1% and the Nasdaq dropping 1.4% amid a sharp semiconductor sector rout and fresh AI competition concerns after Chinese startup Moonshot unveiled Kimi K3, its powerful open-source AI model. Small caps faced additional pressure from a risk-off environment driven by escalating U.S.-Iran military exchanges threatening Strait of Hormuz oil flows and rising crude prices, though the Financial Services sector ETF (XLF) showed relative resilience, edging higher in after-hours trade as big bank earnings — including blowout results from Goldman Sachs — provided an offsetting tailwind for financials-linked holdings within the fund.

-0.6613

July 16, 2026Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF edged up modestly on Wednesday, closing near its 52-week high of $92.00, as several of its top holdings showed mixed but broadly constructive signals. Fintech holding Dave Inc. surged on continued institutional accumulation and UBS raising its price target to $470, while Alkermes advanced on sustained Phase 2 narcolepsy trial data supporting its orexin pipeline ahead of Q2 earnings on July 28. The broader small-cap backdrop was supported by softer inflation data and favorable macro conditions, even as a chipmaker-led selloff weighed on the Nasdaq and the financial sector ETF (XLF) hovered near 52-week highs.

0.4983

July 15, 2026Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF edged up modestly as broad market sentiment improved following a cooler-than-expected June CPI report and a strong start to Q2 earnings season. Major bank holdings benefited from blowout results at JPMorgan, Goldman Sachs, Bank of America, and Citigroup, while top ETF holdings including Dave Inc. (DAVE) rallied sharply on continued fintech momentum and 10x Genomics (TXG) surged on raised analyst price targets and a new Cleveland Clinic collaboration. Above-average volume—running well ahead of the 30-day average—suggests heightened investor interest in small-cap exposure amid the improving macro backdrop.

0.2888

July 14, 2026Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF edged up modestly on Tuesday, outperforming the broader financial sector as markets digested a cooler-than-expected June CPI print showing headline inflation at 3.5% — its lowest since 2020 — which lifted growth-sensitive assets including small caps. The ETF's top holdings provided mixed but net-positive contributions: Alkermes (ALKS) rallied on nine-month narcolepsy drug trial data, Dave Inc. (DAVE) surged ~7% on fintech momentum, and 10x Genomics (TXG) jumped ~9% on raised analyst price targets, while StoneX (SNEX) and Penguin Solutions (PENG) faced modest headwinds. Macro tailwinds from easing rate-hike fears offset ongoing US-Iran geopolitical tensions that had weighed on sentiment the prior session.

0.2896

July 9, 2026Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF gained 1.50% on above-average volume (roughly double its average), outperforming the broader S&P 500 which ended the session modestly higher amid ongoing U.S.-Iran geopolitical tensions. Several top holdings contributed positively, including Enova International (ENVA), which was upgraded to Buy by Zacks and had its price target raised to $250 by TD Cowen, and 10x Genomics (TXG), which surged to a 52-week high after an earnings beat and multiple analyst price target increases. Alkermes (ALKS), the fund's largest holding, also remained in focus following the termination of its Amneal generic VIVITROL supply agreement, while Catalyst Pharmaceuticals (CPRX) saw stockholders approve its merger with Angelini Pharma, clearing a key hurdle for the deal.

1.5016

July 8, 2026Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF closed down nearly 1%, pressured by a broad risk-off session as renewed U.S.-Iran hostilities sent oil prices surging over 4% and rattled equity markets broadly. Small caps faced additional headwinds from rising Treasury yields and inflation concerns ahead of Fed minutes, with the E-mini Russell 2000 futures also declining on the day. Top holdings Enova International (ENVA) and Dave (DAVE) remain focal points, with ENVA attracting bullish analyst upgrades from Jefferies and TD Cowen despite valuation questions, while DAVE faces scrutiny over whether its AI-driven lending model can sustain its elevated multiple.

-0.9875

July 7, 2026Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF closed modestly lower as U.S. equities faced broad selling pressure on Tuesday, with the S&P 500 declining roughly 0.7% amid rising Treasury yields, renewed geopolitical tension after Iranian missile strikes on Strait of Hormuz shipping lanes, and chip sector weakness that dragged on risk sentiment. Several top GSSC holdings saw notable individual developments: Enova International (ENVA) drew fresh analyst attention after TD Cowen raised its price target to $250 with a Buy rating following strong Q1 earnings, while Dave Inc. (DAVE) appointed a new CTO to advance its AI-driven lending platform. The broader small-cap backdrop remains constructive after the Russell 2000 surged 22% in H1 2026, its best first-half since 1991, though near-term macro headwinds from elevated yields and geopolitical uncertainty are weighing on sentiment.

-0.8753

July 6, 2026Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF edged up modestly, closing near its 52-week high of $92.00, as small-cap sentiment got a lift from a broad Wall Street advance led by a semiconductor rebound. Key holdings drove the narrative: Enova International (ENVA) drew attention after BTIG named it a top small-cap pick, citing its AI-driven lending model, while ViaSat (VSAT) and Alkermes (ALKS) benefited from a fresh analyst upgrade and Russell 2000 index inclusion, respectively. Macro tailwinds included a weaker-than-expected June jobs report easing rate-hike fears, with investors now watching Fed minutes and Q2 earnings season for signals on whether the small-cap rally can extend further.

0.5261

TradingView · July 17, 2026GSSC ETF Profile: Dividends, Returns (AMEX:GSSC)TradingView · July 16, 2026GSSC ETF Profile: Dividends, Returns (BOATS:GSSC)AD HOC NEWS · July 4, 2026The Goldman Sachs ActiveBeta U.S. Large Cap Equity ETF - Quietly reshaping core portfoliosStock Traders Daily · May 13, 2026How Goldman Sachs Activebeta U.s. Small Cap Equity Etf (GSSC) Affects Rotational Strategy Timing

Peers

S&P 500SPX · $7,457.69-1.01%Xtrackers MSCI Europe Hedged Equity ETFDBEU · $53.43-0.13%Invesco Russell 1000 Equal Weight ETFEQAL · $59.04-0.57%State Street SPDR S&P Emerging Markets Small Cap ETFEWX · $69.35-2.34%First Trust Developed Markets ex-US AlphaDEX FundFDT · $89.59-0.72%iShares Currency Hedged MSCI Eurozone ETFHEZU · $48.23-0.29%John Hancock Multifactor Emerging Markets ETFJHEM · $38.01-0.82%John Hancock Investments - Multifactor Developed International ETFJHMD · $44.53-0.47%Oakmark U.S. Large Cap ETFOAKM · $29.27-0.98%Opus Small Cap Value Plus ETFOSCV · $42.49-0.68%Tortoise North American Pipeline FundTPYP · $43.66+0.23%